Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group

• A. M. Fein

収録刊行物

• JAMA: The Journal of the American Medical Association

  JAMA: The Journal of the American Medical Association 277 (6), 482-487, 1997-02-12

  American Medical Association (AMA)

キーワード

• General Medicine

詳細情報

• CRID: 1362825896208620288
• NII論文ID: 30005359871
• NII書誌ID: AA00692850
• DOI: 10.1001/jama.277.6.482
• ISSN: 15383598
• ISSN: 00987484
• データソース種別:
  • Crossref
  • CiNii Articles